Author(s):
John Masilamani Nachimuthu, Johnson Vijayakumar Paulraj, Dinesh Kumar Suganandam, Sheeba Rani Paul
Email(s):
johnmasilamani87@gmail.com
DOI:
10.52711/2349-2996.2026.00038 
Address:
John Masilamani Nachimuthu, Johnson Vijayakumar Paulraj, Dinesh Kumar Suganandam, Sheeba Rani Paul
College of Nursing, CMC, Vellore.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2026
ABSTRACT:
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome is a rare, severe, and potentially life-threatening adverse drug reaction characterized by fever, rash, eosinophilia, and multi-organ involvement. DRESS syndrome has a rare occurrence with an estimated incidence ranging from 1:1000 to 1:10,000 drug exposures. It can manifest in a wide range of symptoms, which often appear one to eight weeks after starting the trigger medication. Most of the diagnostic criteria are replaced by the validated RegiSCAR scoring system. The complexities of managing this condition include the importance of early recognition, withdrawal of the culprit drug, and the use of systemic corticosteroids. This case study underscores the critical role of interdisciplinary collaboration among clinicians, allergists, dermatologists, and nurses in achieving a favorable outcome for the patient. Furthermore, it emphasizes the need for heightened awareness among healthcare providers regarding the potential for DRESS syndrome when encountering patients with drug-induced skin eruptions and systemic symptoms.
Cite this article:
John Masilamani Nachimuthu, Johnson Vijayakumar Paulraj, Dinesh Kumar Suganandam, Sheeba Rani Paul. DRESS – A Deathly Syndrome: Case Report from a Tertiary Care Centre in South India. Asian Journal of Nursing Education and Research. 2026;16(3):189-4. doi: 10.52711/2349-2996.2026.00038
Cite(Electronic):
John Masilamani Nachimuthu, Johnson Vijayakumar Paulraj, Dinesh Kumar Suganandam, Sheeba Rani Paul. DRESS – A Deathly Syndrome: Case Report from a Tertiary Care Centre in South India. Asian Journal of Nursing Education and Research. 2026;16(3):189-4. doi: 10.52711/2349-2996.2026.00038 Available on: https://www.ajner.com/AbstractView.aspx?PID=2026-16-3-8
REFERENCES:
1. Choudhary S, McLeod M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthetic Dermatol. 2013 Jun; 6(6): 31–7.
2. Stirton H, Shear NH, Dodiuk-Gad RP. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS. Biomedicines. 2022 May; 10(5): 999.
3. De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. Indian J Dermatol. 2018; 63(1): 30–40.
4. Jampani D, Rohini PM, Raju SU, Shravya E. To Observe the patterns of Cutaneous Adverse Drug Reactions in a Tertiary health care teaching hospital in Hyderabad. Research Journal of Pharmacy and Technology. 2024; 17(1): 131-6.
5. Castellazzi ML, Esposito S, Claut LE, Daccò V, Colombo C. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis. Ital J Pediatr. 2018 Aug 15; 44(1): 93.
6. Cho YT, Yang CW, Chu CY. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. Int J Mol Sci. 2017 Jun 9; 18(6): 1243.
7. Ksouda K, Affes H, Mahfoudh N, Chtourou L, Kammoun A, Charfi A, et al. HLA-A 31:01 and carbamazepine-induced DRESS syndrom in a sample of North African Population. Seizure. 2017 Dec; 53: 42–6.
8. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med. 2011 Jul; 124(7): 588–97.
9. Abubakar AR, Simbak NB, Haque M. Adverse drug reactions: predisposing factors, modern classifications and causality assessment. Research Journal of Pharmacy and Technology. 2014 Sep 1; 7(9): 14.
10. Rayees NM, Kumar S, Raj BK, Rajesh KS, Joel JJ, Shama PK, Gururaja MP, Nandakumar UP. A prospective observational study on adverse drug reactions in general medicine department of a tertiary care teaching hospital. Research Journal of Pharmacy and Technology. 2019 May 1; 12(5): 2289-98.
11. Ganeshanandan L, Lucas M. Drug reaction with eosinophilia and systemic symptoms: a complex interplay between drug, T cells, and herpesviridae. International Journal of Molecular Sciences. 2021 Jan 23; 22(3): 1127.
12. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996 Dec; 15(4): 250–7.
13. Sardana K, Sinha S, Rani S. Compendium Of Dermatology For Examinations. 3rd Ed. CBS Publishers. 2023.
14. Kardaun SH, Mockenhaupt M, Roujeau JC. Comments on: DRESS syndrome. J Am Acad Dermatol. 2014 Nov; 71(5): 1000-1000.e2.
15. Biradar KV, Pawar A. Corticosteroids and way of inflammation. Research Journal of Pharmacology and Pharmacodynamics. 2012; 4(1): 45.
16. Sonawane TN, Dhangar RD, Chaudhari DD. Application of Steroids in Clinical practice. Asian Journal of Research in Pharmaceutical Science. 2022 Mar 1; 12(1).
17. Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: A literature review and treatment algorithm. World Allergy Organ J. 2023 Apr 8; 16(3): 100673.
18. Gulanick M, Myers JL. Nursing care plans: Diagnoses, interventions, and outcomes. Elsevier Health Sciences; 2011.